Dr. Bergman is the Director of Clinical Studies for VCA. He is an adjunct faculty member of the Memorial Sloan-Kettering Cancer Center and the principal veterinary investigator for the canine melanoma vaccine (Oncept®), which was fully licensed in 2009. Prior to Dr. Bergman joining VCA, he served as the Chief Medical Officer for BrightHeart Veterinary Centers from 2007 to 2011; from 1999 – 2007 he was the head of the Donaldson-Atwood Cancer Center at AMC. After finishing veterinary school from Colorado State in 1990, he was an intern at Kansas State (‘90-‘91) and returned to CSU for his medical oncology residency (‘91-‘94) and then completed a PhD Fellowship in human cancer biology from the M.D. Anderson Cancer Center in Houston (‘94-‘99). He was previously Chair of the ACVIM Board of Regents and President of the Veterinary Cancer Society.